Market Cap
$91.4M
NTRB
NutriBand Inc.
$7.36 ▼ -2.13%
Prev close $7.52Market cap$91.4M
12-mo target$15.00 (+106.0%)
Healthcare & Medical Devices
Snapshot
The big-picture read on NTRB right now — valuation, ownership and activity at a glance.
Cap Size
Micro Cap
Inst. Holders
13 funds
Inst. Value
$1.1M
Inst. Activity
0 buys / 1 sells
Press Releases
1
Price chart 30d +30.7%
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
No data for this timeframe.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 1, 2026 activist
Nutriband Marks Five Years on Nasdaq – CEO Letter to Shareholders
Nutriband Marks Five Years on Nasdaq – CEO Letter to Shareholders
Jun 30, 2026 Inst.
UBS Group AG — NEAR_EXIT
672 shares ($2.1K)
Mar 31, 2026 Inst.
Mar 30, 2026 Press UBS Group AG — DOUBLED
32,664 shares ($115.3K)
Nutriband Inc. announced the selection of a commercial worldwide brand name for its lead product, an abuse-deterrent fen
Impact 3/10
Analyst ratings buy % +0.0%
How Wall Street rates the stock today, and the latest firm-by-firm actions.
Recent analyst actions
| Date | Firm | Action | Rating | Firm rating |
|---|---|---|---|---|
| Jan 22, 2025 | Noble Capital Markets | INITIATE | Outperform | 64% |
| Jul 26, 2022 | Small Cap Consumer Research | MAINTAIN | Buy | 45% |
Monthly consensus history
| Period | Str. Buy | Buy | Hold | Sell | Str. Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Aug 1, 2026 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Jul 1, 2026 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Jun 1, 2026 | 2 | 4 | 1 | 0 | 0 | 86% | |
| May 1, 2026 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Apr 1, 2026 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Mar 1, 2026 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Feb 1, 2026 | 2 | 4 | 1 | 0 | 0 | 86% |
Price targets
Where 1 covering analysts think NTRB trades over the next 12 months.
$15.00 +106.0% upside Strong Buy
Current$7.28 Low$15.00 Median$15.00 High$15.00 1 analysts
$15.00$15.00
Analyst rating None as of Oct 3, 2026
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
Upcoming & catalyst events
Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.
Oct 1, 2026
activist
Nutriband Marks Five Years on Nasdaq – CEO Letter to Shareholders
Nutriband Marks Five Years on Nasdaq – CEO Letter to Shareholders
Sep 29, 2026
other
Nutriband CEO Gareth Sheridan Featured in New Nick Shirley Documentary Confronting America's Opioid Crisis
Nutriband CEO Gareth Sheridan Featured in New Nick Shirley Documentary Confronting America's Opioid Crisis
Sep 25, 2026
other
Nutriband Appoints Decorated Navy SEAL and Veterans Health Advocate Robert J. O'Neill to Advisory Board
Nutriband Appoints Decorated Navy SEAL and Veterans Health Advocate Robert J. O'Neill to Advisory Board
Sep 9, 2026
other
Nutriband CEO, Gareth Sheridan to Attend the Nasdaq Life Sciences Advisory Board (LaB) Biotech Summit
NUTRIBAND CEO, GARETH SHERIDAN TO ATTEND THE INAUGURAL NASDAQ LIFE SCIENCES ADVISORY BOARD (LAB) BIOTECH SUMMIT
Sep 7, 2026
earnings_calendar
NTRB Q2 2027 Earnings Scheduled — 2026-09-07
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
| Period | EPS Est. | Range | Growth | 30d Rev | Up/Dn | Revenue | # |
|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00–$0.00 | — | — | — | $0.0B | — |
| Next Q | $0.00 | $0.00–$0.00 | — | — | — | $0.0B | — |
| Current FY | $0.00 | $0.00–$0.00 | — | — | — | $0.0B | — |
| Next FY | $0.00 | $0.00–$0.00 | — | — | — | $0.0B | — |
Institutional ownership
Which big funds own NTRB (from quarterly 13F filings) and who is adding or trimming.
13 institutional holders with $1.1M total value (338,867 shares) as of 2026-Q2. Top holders: VANGUARD, GEODE, VANGUARD. Net selling activity: 1 institutions trimmed/exited vs 0 added.
Top holders — 2026-Q2
| Fund | Shares | Value | % Tracked | Last move |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 174,927 | $558.0K | 51.6% | — |
| GEODE CAPITAL MANAGEMENT, LLC | 62,494 | $199.4K | 18.4% | — |
| VANGUARD FIDUCIARY TRUST CO | 25,111 | $80.1K | 7.4% | — |
| STATE STREET CORP | 24,966 | $79.6K | 7.4% | ADD +44.6% |
| CITADEL ADVISORS LLC | 18,996 | $60.6K | 5.6% | — |
| NORTHERN TRUST CORP | 11,570 | $36.9K | 3.4% | — |
| BlackRock, Inc. | 10,662 | $34.0K | 3.1% | — |
| OSAIC HOLDINGS, INC. | 3,684 | $11.8K | 1.1% | — |
| Vanguard Global Advisers, LLC | 2,700 | $8.6K | 0.8% | — |
| WELLS FARGO & COMPANY/MN | 2,600 | $8.3K | 0.8% | — |
Recent position changes
| Fund | Action | Prev | Current | Change | Value |
|---|---|---|---|---|---|
| UBS Group AG | NEAR_EXIT | 32,664 | 672 | -97.9% | $2.1K |
| UBS Group AG | DOUBLED | 1,249 | 32,664 | +2515.2% | $115.3K |
| Cetera Investment Advisers | TRIM | 18,900 | 11,400 | -39.7% | $51.8K |
| UBS Group AG | NEAR_EXIT | 19,637 | 1,249 | -93.6% | $5.7K |
| BANK OF AMERICA CORP /DE/ | TRIM | 198 | 106 | -46.5% | $481.00 |
| UBS Group AG | DOUBLED | 1 | 19,637 | +1963600.0% | $138.4K |
| STATE STREET CORP | ADD | 17,266 | 24,966 | +44.6% | $196.5K |
| UBS Group AG | NEAR_EXIT | 4,328 | 1 | -100.0% | $8.00 |
| UBS Group AG | TRIM | 6,241 | 4,328 | -30.7% | $26.5K |
| BANK OF AMERICA CORP /DE/ | TRIM | 130 | 43 | -66.9% | $264.00 |
Short interest & halts
FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for NTRB.
Shares short
177,805
Settlement Sep 15, 2026
Change vs prior
+3.1%
Semi-monthly cycle
Days to cover
2.2
At avg daily volume
Of shares outstanding
≈1.5%
Estimate — not % of float
All NTRB filing & press-release reports (1)
- PRESS-RELEASE reportMar 30, 2026